Scoring systems predict the prognosis of acute-on-chronic hepatitis B liver failure: an evidence-based review

References

• Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009;3(1):269-82
   PubMed Web of Science ®Google Scholar
• Seto WK, Lai CL, Yuen MF. Acute-on-chronic liver failure in chronic hepatitis B. J Gastroenterol Hepatol 2012;27(4):662-9
   PubMed Web of Science ®Google Scholar
• Cui YL, Yan F, Wang YB, et al. Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure. Dig Dis Sci 2010;55(8):2373-80
   PubMedGoogle Scholar
• Avolio AW, Nure E, Pompili M, et al. Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches. Transplant Proc 2008;40(6):1961-4
   PubMed Web of Science ®Google Scholar
• Liu J, Fan D. Hepatitis B in China. Lancet 2007;369(9573):1582-3
   PubMed Web of Science ®Google Scholar
• Chan AC, Fan ST, Lo CM, et al. Liver transplantation for acute-on-chronic liver failure. Hepatol Int 2009;3(4):571-81
   PubMed Web of Science ®Google Scholar
• Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology 2002;36(1):227-42
   PubMed Web of Science ®Google Scholar
• Brown RS Jr, Russo MW, Lai M, et al. A survey of liver transplantation from living adult donors in the United States. N Engl J Med 2003;348(9):818-25
   PubMedGoogle Scholar
• Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6(4):783-90
   PubMed Web of Science ®Google Scholar
• Desai NM, Mange KC, Crawford MD, et al. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004;77(1):99-106
   PubMedGoogle Scholar
• Amin MG, Wolf MP, TenBrook JA Jr, et al. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl 2004;10(12):1468-75
   PubMed Web of Science ®Google Scholar
• Rull R, Vidal O, Momblan D, et al. Evaluation of potential liver donors: limits imposed by donor variables in liver transplantation. Liver Transpl 2003;9(4):389-93
   PubMedGoogle Scholar
• Karvellas CJ, Pink F, McPhail M, et al. Bacteremia, acute physiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure. Crit Care Med 2010;38(1):121-6
   PubMed Web of Science ®Google Scholar
• Garg H, Sarin SK, Kumar M, et al. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology 2011;53(3):774-80
   PubMed Web of Science ®Google Scholar
• Novelli G, Rossi M, Ferretti G, et al. Predictive parameters after molecular absorbent recirculating system treatment integrated with model for end stage liver disease model in patients with acute-on-chronic liver failure. Transplant Proc 2010;42(4):1182-7
   PubMedGoogle Scholar
• Shi F, Zhang JY, Zeng Z, et al. Skewed ratios between CD3(+) T cells and monocytes are associated with poor prognosis in patients with HBV-related acute-on-chronic liver failure. Biochem Biophys Res Commun 2010;402(1):30-6
   PubMed Web of Science ®Google Scholar
• Wlodzimirow KA, Eslami S, Abu-Hanna A, et al. A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality. Liver Int 2013;33(1):40-52
   PubMed Web of Science ®Google Scholar
• Lee KW, Cameron AM, Maley WR, et al. Factors affecting graft survival after adult/child split-liver transplantation: analysis of the UNOS/OPTN data base. Am J Transplant 2008;8(6):1186-96
   PubMed Web of Science ®Google Scholar
• Lee KW, Simpkins CE, Montgomery RA, et al. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation 2006;82(12):1683-8
   PubMedGoogle Scholar
• Detre KM, Lombardero M, Belle S, et al. Influence of donor age on graft survival after liver transplantation--United Network for Organ Sharing Registry. Liver Transpl Surg 1995;1(5):311-19
   PubMedGoogle Scholar
• Hoofnagle JH, Lombardero M, Zetterman RK, et al. Donor age and outcome of liver transplantation. Hepatology 1996;24(1):89-96
   PubMed Web of Science ®Google Scholar
• Busquets J, Xiol X, Figueras J, et al. The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation 2001;71(12):1765-71
   PubMedGoogle Scholar
• Angelico M, Nardi A, Marianelli T, et al. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study. J Hepatol 2013;58(4):715-23
   Google Scholar
• Yang SS, Cheng KS, Lai YC, et al. Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B. J Gastroenterol 2002;37(8):626-32
   PubMed Web of Science ®Google Scholar
• Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124(1):91-6
   PubMed Web of Science ®Google Scholar
• Wang ZX, Yan LN, Wang WT, et al. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure. Transplant Proc 2007;39(5):1501-4
   PubMedGoogle Scholar
• Wong VW, Chim AM, Wong GL, et al. Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B. Liver Transpl 2007;13(9):1228-35
   PubMed Web of Science ®Google Scholar
• Yu JW, Sun LJ, Zhao YH, Li SC. Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment. J Gastroenterol Hepatol 2008;23(8 Pt 1):1242-9
   PubMedGoogle Scholar
• Cuomo O, Perrella A, Arenga G. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system? Transplant Proc 2008;40(6):1906-9
   PubMed Web of Science ®Google Scholar
• Sun QF, Ding JG, Xu DZ, et al. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model. J Viral Hepat 2009;16(7):464-70
   PubMedGoogle Scholar
• Sun LJ, Yu JW, Zhao YH, et al. Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure. J Gastroenterol Hepatol 2010;25(3):583-90
   PubMed Web of Science ®Google Scholar
• Lee WC, Chou HS, Wu TJ, et al. Indicators and outcome of liver transplantation in acute liver decompensation after flares of hepatitis B. J Viral Hepat 2011;18(3):193-9
   PubMedGoogle Scholar
• Huang K, Hu JH, Wang HF, et al. Survival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 2011;17(29):3448-52
   PubMed Web of Science ®Google Scholar
• Zheng MH, Shi KQ, Fan YC, et al. A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure. Clin Gastroenterol Hepatol 2011;9(4):351-6; e353
   PubMed Web of Science ®Google Scholar
• Zheng YB, Xie DY, Gu YR, et al. Development of a sensitive prognostic scoring system for the evaluation of severity of acute-on-chronic hepatitis B liver failure: a retrospective cohort study. Clin Invest Med 2012;35(2):E75-85
   Google Scholar
• Zheng MH, Shi KQ, Lin XF, et al. A model to predict 3-month mortality risk of acute-on-chronic hepatitis B liver failure using artificial neural network. J Viral Hepat 2013;20(4):248-55
   PubMed Web of Science ®Google Scholar
• Jalan R, Gines P, Olson JC, et al. Acute-on chronic liver failure. J Hepatol 2012;57(6):1336-48
   PubMedGoogle Scholar
• Halldorson JB, Bakthavatsalam R, Fix O, et al. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant 2009;9(2):318-26
   PubMed Web of Science ®Google Scholar
• O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97(2):439-45
   PubMed Web of Science ®Google Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60(8):646-9
   PubMed Web of Science ®Google Scholar
• Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31(4):864-71
   PubMed Web of Science ®Google Scholar
• Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22(7):707-10
   PubMed Web of Science ®Google Scholar
• Cucchetti A, Vivarelli M, Heaton ND, et al. Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. Gut 2007;56(2):253-8
   PubMedGoogle Scholar
• Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005;41(5):1179-97
   PubMed Web of Science ®Google Scholar
• Bailey B, Amre DK, Gaudreault P. Fulminant hepatic failure secondary to acetaminophen poisoning: a systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med 2003;31(1):299-305
   PubMed Web of Science ®Google Scholar
• Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg 1964;1:1-85
   PubMedGoogle Scholar
• Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987;7(4):660-4
   Google Scholar
• Kim WR, Poterucha JJ, Wiesner RH, et al. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology 1999;29(6):1643-8
   PubMedGoogle Scholar
• Lucey MR, Brown KA, Everson GT, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997;3(6):628-37
   PubMedGoogle Scholar
• Tillmann HL, Hadem J, Leifeld L, et al. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat 2006;13(4):256-63
   PubMed Web of Science ®Google Scholar
• Hong G, Lee KW, Suh S, et al. The model for end-stage liver disease score-based system predicts short term mortality better than the current Child-Turcotte-Pugh score-based allocation system during waiting for deceased liver transplantation. J Korean Med Sci 2013;28(8):1207-12
   PubMedGoogle Scholar
• Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006;130(6):1652-60
   PubMed Web of Science ®Google Scholar
• Heuman DM, Abou-Assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004;40(4):802-10
   PubMed Web of Science ®Google Scholar
• Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004;40(6):897-903
   PubMed Web of Science ®Google Scholar
• Wang D, Wang Q, Shan F, et al. Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers. BMC Infect Dis 2010;10:251
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13(10):818-29
   PubMed Web of Science ®Google Scholar
• Avolio AW, Halldorson JB, Burra P, et al. Balancing utility and need by means of donor-to-recipient matching: a challenging problem. Am J Transplant 2013;13(2):522-3
   PubMedGoogle Scholar
• Avolio AW, Cillo U, Salizzoni M, et al. Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. Am J Transplant 2011;11(12):2724-36
   PubMed Web of Science ®Google Scholar
• Avolio AW, Agnes S, Cillo U, et al. http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation. Transpl Int 2012;25(3):294-301
   PubMed Web of Science ®Google Scholar
• D-MELD Group. Available from: www.D-MELD.com
   Google Scholar
• Gridelli B, Remuzzi G. Strategies for making more organs available for transplantation. N Engl J Med 2000;343(6):404-10
   PubMed Web of Science ®Google Scholar
• Trotter JF, Wachs M, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 2002;346(14):1074-82
   PubMed Web of Science ®Google Scholar
• Thuluvath PJ, Yoo HY. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation. Liver Transpl 2004;10(10):1263-8
   PubMed Web of Science ®Google Scholar
• Hu A, Liang W, Zheng Z, et al. Living donor vs. deceased donor liver transplantation for patients with hepatitis C virus-related diseases. J Hepatol 2012;57(6):1228-43
   PubMed Web of Science ®Google Scholar
• Fisher RA, Cotterell AH, Maluf DG, et al. Adult living donor versus deceased donor liver transplantation: a 10-year prospective single center experience. Ann Hepatol 2009;8(4):298-307
   PubMedGoogle Scholar
• Laleman W, Verbeke L, Meersseman P, et al. Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions. Expert Rev Gastroenterol Hepatol 2011;5(4):523-37; quiz 537
   PubMed Web of Science ®Google Scholar
• Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004;351(15):1521-31
   PubMed Web of Science ®Google Scholar
• Hoofnagle JH, Doo E, Liang TJ, et al. Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007;45(4):1056-75
   PubMed Web of Science ®Google Scholar
• Xu X, Liu X, Ling Q, et al. Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure. PLoS One 2013;8(3):e58738
   PubMed Web of Science ®Google Scholar
• Du WB, Li LJ, Huang JR, et al. Effects of artificial liver support system on patients with acute or chronic liver failure. Transplant Proc 2005;37(10):4359-64
   PubMedGoogle Scholar
• Liu T, Zhang C, Wang Y. Proper antiviral therapy for hepatitis B virus-associated acute-on-chronic liver failure. Hepatology 2011;54(2):747-8
   PubMedGoogle Scholar
• Garg H, Sarin SK, Kumar M, et al. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology 2011;54(3):1114-14
   Google Scholar
• Wong VW, Wong GL, Yiu KK, et al. Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B. J Hepatol 2011;54(2):236-42
   PubMed Web of Science ®Google Scholar
• Gaspari R, Avolio AW, Zileri Dal Verme L, et al. Molecular adsorbent recirculating system in liver transplantation: safety and efficacy. Transplant Proc 2006;38(10):3544-51
   PubMedGoogle Scholar
• Donati G, La Manna G, Cianciolo G, et al. Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up. Artif Organs 2014;38(2):125-34
   PubMed Web of Science ®Google Scholar
• Banares R, Nevens F, Larsen FS, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology 2013;57(3):1153-62
   PubMed Web of Science ®Google Scholar
• Kim WR, Poterucha JJ, Kremers WK, et al. Outcome of liver transplantation for hepatitis B in the United States. Liver Transpl 2004;10(8):968-74
   PubMedGoogle Scholar
• Valadao RM, Terrault NA. Older donors: mounting risks for the hepatitis C-infected liver transplant recipient? Liver Transpl 2009;15(7):677-81
   PubMedGoogle Scholar
• Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King’s criteria. J Hepatol 1997;26(1):62-8
   PubMed Web of Science ®Google Scholar
• Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005;42(6):1364-72
   PubMed Web of Science ®Google Scholar
• Dhiman RK, Jain S, Maheshwari U, et al. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King’s College Hospital criteria. Liver Transpl 2007;13(6):814-21
   PubMedGoogle Scholar
• Ruf AE, Kremers WK, Chavez LL, et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005;11(3):336-43
   PubMed Web of Science ®Google Scholar